SK19396A3 - Pharmaceutical composition for oral administration comprising micronized progesterone and a polyethyelene glycol together with an excipient and producing method of this composition - Google Patents

Pharmaceutical composition for oral administration comprising micronized progesterone and a polyethyelene glycol together with an excipient and producing method of this composition Download PDF

Info

Publication number
SK19396A3
SK19396A3 SK193-96A SK19396A SK19396A3 SK 19396 A3 SK19396 A3 SK 19396A3 SK 19396 A SK19396 A SK 19396A SK 19396 A3 SK19396 A3 SK 19396A3
Authority
SK
Slovakia
Prior art keywords
starch
progesterone
pharmaceutical composition
estradiol
oral administration
Prior art date
Application number
SK193-96A
Other languages
English (en)
Slovak (sk)
Inventor
Karen S Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of SK19396A3 publication Critical patent/SK19396A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SK193-96A 1993-08-20 1994-08-19 Pharmaceutical composition for oral administration comprising micronized progesterone and a polyethyelene glycol together with an excipient and producing method of this composition SK19396A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (1)

Publication Number Publication Date
SK19396A3 true SK19396A3 (en) 1997-03-05

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
SK193-96A SK19396A3 (en) 1993-08-20 1994-08-19 Pharmaceutical composition for oral administration comprising micronized progesterone and a polyethyelene glycol together with an excipient and producing method of this composition

Country Status (17)

Country Link
EP (1) EP0789560A1 (ko)
JP (1) JPH09501682A (ko)
KR (1) KR960703570A (ko)
CN (1) CN1132478A (ko)
AU (1) AU7530594A (ko)
BR (1) BR9407306A (ko)
CA (1) CA2169840A1 (ko)
CZ (1) CZ42596A3 (ko)
DK (1) DK95093D0 (ko)
FI (1) FI960749A0 (ko)
HU (1) HUT74167A (ko)
LT (1) LT4043B (ko)
NO (1) NO960653D0 (ko)
NZ (1) NZ271617A (ko)
PL (1) PL313113A1 (ko)
SK (1) SK19396A3 (ko)
WO (1) WO1995005807A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) * 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
DK1598069T3 (da) * 1999-08-31 2009-07-06 Bayer Schering Pharma Ag Farmaceutisk præparat af ethinylestradiol og drospirenon til anvendelse som præventionsmiddel
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
CA2479295A1 (en) * 2002-03-14 2003-09-25 Thomas C. Ho Progesterone oral drug delivery system
DE602004016311D1 (de) * 2003-04-29 2008-10-16 Organon Nv Verfahren zur verfestigung, bei welchem ein anti-lösungsmittel benutzt wird
WO2007030153A2 (en) 2005-04-28 2007-03-15 Wyeth Compositions containing micronized tanaproget
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
NZ271617A (en) 1996-11-26
KR960703570A (ko) 1996-08-31
CZ42596A3 (en) 1996-06-12
LT4043B (en) 1996-09-25
EP0789560A1 (en) 1997-08-20
NO960653L (no) 1996-02-19
DK95093D0 (da) 1993-08-20
PL313113A1 (en) 1996-06-10
WO1995005807A1 (en) 1995-03-02
AU7530594A (en) 1995-03-21
CN1132478A (zh) 1996-10-02
FI960749A (fi) 1996-02-19
CA2169840A1 (en) 1995-03-02
HU9600376D0 (en) 1996-04-29
LT96010A (ko) 1996-06-25
NO960653D0 (no) 1996-02-19
FI960749A0 (fi) 1996-02-19
JPH09501682A (ja) 1997-02-18
BR9407306A (pt) 1996-10-08
HUT74167A (en) 1996-11-28

Similar Documents

Publication Publication Date Title
SK19396A3 (en) Pharmaceutical composition for oral administration comprising micronized progesterone and a polyethyelene glycol together with an excipient and producing method of this composition
CN1273141C (zh) 包含17β－雌二醇－3－低级链烷酸酯的口服药品和制备方法
KR102539030B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
JP2004533419A (ja) ホルモン補充療法
EP1990044A1 (en) Mifepristone pharmaceutical compositions and their methods of preparation
RU2261106C2 (ru) Гормональная композиция на основе гестагена и эстрогена и ее применение
US5891867A (en) Hormonal medicaments and their use for the correction of oestrogenic deficiencies
SK285056B6 (sk) Použitie estroprogestatívnej hormonálnej kompozície
RU2258512C2 (ru) Противозачаточное лекарственное средство на основе гестагена и эстрогена и способ его получения
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン
CN114569567B (zh) 一种稳定的双醋炔诺酮炔雌醇复方片及其制备方法
EP2863900B1 (en) Formulations for the preparation of immediate-release tablets for oral administration containing low-dose mifepristone, tablets thus obtained and their preparation process
CN114129530A (zh) 一种黄体酮缓释组合物及其制备方法
AU771059B2 (en) Use of antiprogestagens in combined therapy
JPH1171268A (ja) 性ホルモン含有錠剤